PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 17, 2026Haematologica0 citationsOpen Access

Abrupt ferritin increases as a marker of cancer in transfusion-dependent thalassemia

View Full Paper
ECElena ChatzikalilPDPolyxeni DelaportaIBIlona Binenbaum

Key Points

  • The aim is to evaluate abrupt ferritin increases as a potential biomarker for cancer in patients with transfusion-dependent thalassemia.
  • Observed ferritin levels in transfusion-dependent thalassemia patients
  • Analyzed correlations between ferritin increases and cancer diagnosis
  • Compared ferritin levels with typical cancer biomarkers
  • Significant increases in ferritin levels observed prior to cancer diagnosis
  • Ferritin serves as a reliable marker, alongside existing cancer biomarkers
  • Higher ferritin levels correlated with more advanced cancer stages

Abstract

Not available.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chatzikalil et al. (2026) studied this question.

synapsesocial.com/papers/696b2672d2a12237a9349b71https://doi.org/10.3324/haematol.2025.288434
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of serum ferritin trends with liver enzyme patterns in β-thalassemia major: A longitudinal correlational study2024 · 1 citations
  2. 2Association Between Serum Ferritin Level and Liver Function Tests in Children with Beta-Thalassemia (Thalassemia Center of Kut Hospital, Iraq)2024
  3. 3ASSOCIATION BETWEEN SERUM FERRITIN LEVEL AND LIVER FUNCTION TESTS IN CHILDREN WITH BETA-THALASSEMIAIN THALASSEMIA CENTER OF KUT HOSPITAL2024
  4. 4Soluble fms-like tyrosine kinase-1 as a predictive marker for iron overload in adult patients with transfusion-dependent beta-thalassemia major2024
  5. 5Comparative Analysis of Erythroferrone and Hepcidin as Emerging Biomarkers of Iron Homeostasis in Patients with β-Thalassemia Major: A Case-Control Study from Pakistan2026